RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..6 of 6 - per page
Order by
This technology overcomes the amount of time required to culture and identify pathogens, using standard collection methods, is able to identify over 98% of relevant pathogens, and is a fully automated process More
A novel selective antimicrobial peptide based on human LL-37 by D-amino acid incorporation. More
A class of secreted staphylococcal peptides with an extraordinary ability to recruit, activate, and subsequently lyse human neutrophils, thus eliminating the main cellular defense against S. aureus infection More
Spraying a tannin-rich hypertonic solution on the throat surface generates hypotonic fluid exudation, detaching all contaminants, hydrating the throat and alleviating the pain. Virus neutralization inhibits further infection. For adults and children. More
CG400549, A Novel Antibiotic for Superbugs Including MRSA, VRSA, and VISA (in Phase I Clinical Development) More
Displaying 1..6 of 6 - per page
Order by

Related Reports

Your selection

Therapeutic target
Infectious diseases del
Nosocomial infections del
Development phase
Early Stage del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us